Non-Invasive Prenatal Testing (PNID) Market Future Business Opportunities 2021-2028 | Women’s health Axia, Eluthia.

Non-invasive prenatal screening (PNID)

The non-invasive prenatal test is an innovative method used in the United States to determine the likelihood of a woman being pregnant with certain genetic abnormalities.

SEATTLE, WASHINGTON, UNITED STATES, December 7, 2021 /EINPresswire.com/ – Presentation

The non-invasive prenatal test is an innovative method used in the United States to determine the likelihood that a woman is pregnant with certain genetic abnormalities, including trisomy 21, trisomy 18, and other chromosomal abnormalities. This test analyzes very small, short pieces of DNA that circulate in a woman’s blood during pregnancy.

Global Non-invasive Prenatal Testing Market: Drivers

Growing awareness regarding NIPT is expected to propel the growth of the global non-invasive prenatal testing market during the forecast period. For example, in September 2020, in China, compared to participants from Zhengzhou, a higher proportion of women from Shenzhen had heard of NIPT (87.30% vs. 64.03%), were willing to receive NIPT (91 , 80% versus 80.43%) and had taken NIPT (83.12% versus 54.54%), while their level of satisfaction was lower, according to researchers from Fudan University, China, and the University College London, United Kingdom

For more business information on requesting a sample report at – https://www.coherentmarketinsights.com/insight/request-sample/579

In addition, the launch of new products is also expected to contribute to the growth of the market. For example, in October 2019, BillionToOne, Inc., a diagnostics company, and Eluthia, a provider of genetic diagnostic tests based in Europe, announced the launch of the UNITY test, a non-invasive prenatal test, in the European region.

Recent developments

Major players operating in the global non-invasive prenatal testing market are focusing on fundraising to increase their market share. For example, in June 2021, BillionToOne raised US $ 55 million. The major players operating in the global non-invasive prenatal testing market are focused on the approval and launch of new products to expand their product portfolio. For example, in November 2019, Health Canada approved the Harmony test, a non-invasive prenatal test from F. Hoffmann-La Roche Ltd. developed for the diagnosis of trisomy 21 (Down syndrome).

Covid-19 impact analysis:

The field of prenatal screening and diagnosis has undergone several changes after the Covid-19 pandemic. However, data on COVID-19 during pregnancy is so far limited. The emergence of Covid-19 has led to an increase in the adoption of NIPT despite the continued decline in the birth rate.

Key points to remember:

The global non-invasive prenatal testing market was estimated at US $ 971.9 million in 2020 and is expected to reach a value of US $ 1,936.4 million by 2027 at a CAGR of 10.3% between 2020 and 2027.

To get the research PDF brochure here @ https://www.coherentmarketinsights.com/insight/request-pdf/579

The increase in the number of women smoking cigarettes is expected to propel the growth of the global non-invasive prenatal testing market during the forecast period. For example, nearly 14 in 100 American adults aged 18 or older smoked cigarettes, according to the Centers for Disease Control and Prevention, in 2018.

The panel 1 testing segment held a dominant position in the global non-invasive prenatal testing market in 2019, accounting for 57.9% share in terms of value.

Global Non-invasive Prenatal Testing Market: Competitive Landscape

The major players operating in the global non-invasive prenatal testing market are Axia Women’s Health, Ariosa Diagnostics, Inc., Berry Genomics Corporation, BillionToOne, Inc., BGI Diagnosis Co., Ltd., Eluthia, Illumina, Inc., LifeCodexx AG , Natera, Inc., Quest Diagnostics Incorporated and Sequenom, Inc.

Get a 2000 USD discount package

To purchase this research report directly – https://www.coherentmarketinsights.com/promo/buynow/579

About Us:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, custom research reports, and advisory services. We are known for our actionable insights and authentic reports in a variety of fields including aerospace and defense, agriculture, food and beverage, automotive, chemicals and materials, and virtually every field. and a comprehensive list of subdomains under the sun. We create value for our clients through our highly reliable and accurate reporting. We are also committed to playing a leading role in providing insight into various post-COVID-19 sectors and continue to deliver measurable and sustainable results to our clients.

Contact us:

Consistent market information
1001 4th Ave, # 3200 Seattle, WA 98154, USA
Email: [email protected]
United States of America: + 1-206-701-6702
United Kingdom: + 44-020-8133-4027
Japan: + 050-5539-1737
India: + 91-848-285-0837

Raj shah
Coherent Market Insights Pvt. Ltd.
+1 206-701-6702
write us here
Visit us on social networks:
Facebook
Twitter
LinkedIn
Other

Comments are closed.